Emerging evidence regarding IL-33 and Wnt/-catenin crosstalk may hold the key to unraveling the complex pathogenesis of EMs
Physician Portals: We create high-utility dashboards for clinicians that highlight patients at risk, allowing for early intervention
doi: 10.1016/j.cmet.2021.12.010 Summary Keywords GIP, GLP-1, obesity, weight loss, tirzepatide, GLP-1R agonists, GIP receptor agonists, Citation Zaffina I, Pelle MC, Armentaro G, Giofr F, Cassano V, Sciacqua A and Arturi F (2023) Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
Barone R, Alaimo S, Messina M, Pulvirenti A, Bastin J, Ferro A, Frye RE, Rizzo R
TB-500 facilitates cellular migration to repair sites
Dietary Supplements as ergogenic Aids Chapter 13